Background: Leptin and adiponectin play a key role in obesity-associated malignancy, particularly in colorectal cancer (CRC). Immunohistochemical (IHC) evaluation of these adipokines may offer valuable prognostic insights in CRC. This study aimed to analyze global publication trends and summarize current knowledge on the potential of these hormones as IHC biomarkers in CRC. Methods: A problem-oriented bibliometric analysis, including publications from 2000 to 2025, was performed across the MEDLINE and Scopus databases. In parallel, a literature review was conducted to present the biological and clinical relevance of these adipokines in CRC. Results and Discussion: A total of 101 publications were identified. Scopus indexed substantially more studies than MEDLINE. The journals Cancer Research, Journal of BUON, Cells, BMC Cancer, and Asian Pacific Journal of Cancer Prevention were identified as the core journals publishing on this topic over the 25-year period. The leading countries were China and the USA. A review of the literature showed that adiponectin is a promising prognostic marker, while leptin appears to be a better indicator of disease progression. Conclusions: IHC research on leptin and adiponectin in CRC is a promising but still underexplored area. Their integration with routine molecular assessment has the potential to improve patient stratification.

Background: Prader–Willi syndrome (PWS) is a multisystemic complex imprinting disorder. Prenatal diagnosis of PWS is still a challenge with non-specific ultrasound markers and limitations for diagnosis with non-invasive screening methods. Prenatal suspicion and early postnatal diagnosis are essential for promoting healthy growth and development, preventing complications, and providing healthcare professionals and families with the necessary support and resources for effective management. Presentation: We report two PWS cases caused by maternal uniparental disomy, who presented with IUGR, characterized by reduced fetal abdominal circumference (AC) in the second and early third trimesters, reduced fetal movements, normal Doppler indices and oligohydramnios. They were diagnosed in the early neonatal period with no prenatal suspicion but with similar ultrasound markers of the developing pregnancies, analyzed retrospectively. Aim: This study aims to emphasize the need to raise awareness among specialists about genetic syndromes such as Prader–Willi syndrome, to improve the information provided to couples regarding the limitations of current prenatal screening methods, as well as to ensure that, in cases of prenatal suspicion, appropriate genetic testing can be initiated. A confirmed diagnosis would allow timely and adequate measures to be taken, given the complications of the postnatal period in these patients and their need for specialized care and management. Conclusions: The presence of the aforementioned prenatal characteristics may raise suspicion for PWS. In such cases, invasive diagnostic procedures and methylation testing may be indicated, enabling earlier diagnosis and timely management, which can ultimately improve the quality of life of affected individuals and their families.

The vaginal microbiota represents a dynamic microbial ecosystem that contributes to mucosal homeostasis and protection against potentially pathogenic microorganisms. Vaginal dysbiosis, characterized by alterations in microbial composition and function, has increasingly been associated with gynecological, reproductive, obstetric, and puerperal conditions. This review summarizes current evidence on the composition and determinants of the vaginal microbiota, with an emphasis on Community State Types and major forms of dysbiosis, including bacterial vaginosis, vulvovaginal candidiasis, aerobic vaginitis, and viral infections. The associations between dysbiosis and sexually transmitted infections are discussed, with particular attention to the distinction between colonization, dysbiosis, and clinically relevant infection. Potential relationships between dysbiosis and infertility are examined, including tubal, cervical, and endometrial factors, as well as outcomes following assisted reproductive technologies. Evidence regarding obstetric and puerperal complications is critically evaluated. Finally, current therapeutic strategies are reviewed, ranging from etiological antimicrobial treatment to probiotics, defined live biotherapeutics, and emerging approaches such as vaginal microbiota transplantation. Although microbiota restoration represents a promising therapeutic concept, uncertainties remain regarding optimal strains, timing, diagnostic criteria, and clinically meaningful outcomes. Overall, vaginal dysbiosis should be regarded not simply as a local microbial imbalance but as a condition capable of modifying mucosal host-pathogen interactions throughout the female reproductive tract.

Background: Leptin and adiponectin play a key role in obesity-associated malignancy, particularly in colorectal cancer (CRC). Immunohistochemical (IHC) evaluation of these adipokines may offer valuable prognostic insights in CRC. This study aimed to analyze global publication trends and summarize current knowledge on the potential of these hormones as IHC biomarkers in CRC. Methods: A problem-oriented bibliometric analysis, including publications from 2000 to 2025 was performed across MEDLINE and Scopus databases. In parallel, a literature review was conducted to present the biological and clinical relevance of these adipokines in CRC. Results and Discussion: A total of 101 publications were identified. Scopus indexed substantially more studies than MEDLINE. The journals Cancer Research, Journal of BUON, Cells, BMC Cancer, and Asian Pacific Journal of Cancer Prevention were identified as the core journals publishing on this topic over the 25-year period. Leading countries were China and USA. A review of the literature showed that adiponectin is a promising prognostic marker, while leptin appears to be a better indicator of disease progression. Conclusions: IHC research on leptin and adiponectin in CRC is a promising but still underexplored area. Their integration with routine molecular assessment has the potential to improve patient stratification.